Correction: Quality Tolerance Limits' Place in the Quality Management System and Link to the Statistical Trial Design: Case Studies and Recommendations from Early Adopters.

Autor: Wolfs M; Integrated Data Analytics and Reporting, Janssen Research and Development, Graaf Engelbertlaan 75, 4837DS, Breda, Netherlands. Mwolfs1@its.jnj.com., Bojarski Ł; Development Operations, AstraZeneca R&D BioPharmaceuticals, ul. Postepu 14, 02-675, Warsaw, Poland., Young S; CluePoints Inc, King of Prussia, PA, USA., Cesario L; Pfizer R&D, New York, NY, USA., Makowski M; Data Strategy and Management, GlaxoSmithKline GmbH & Co. KG, Prinzregentenpl. 9, 81675, Munich, Germany., Sullivan LB; Metrics & Performance Management, WCG, Indianapolis, IN, USA.
Jazyk: angličtina
Zdroj: Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2023 Sep; Vol. 57 (5), pp. 1121.
DOI: 10.1007/s43441-023-00546-w
Databáze: MEDLINE
Externí odkaz: